1 min read

Cleerly’s Technology | An Important Impact On Our Overall Wellness

Health Tech: Dr James Min On How Cleerly’s Technology Can Make An Important Impact On Our Overall Wellness
An Interview With Dave Philistin

In recent years, Big Tech has gotten a bad rep. But of course many tech companies are doing important work making monumental positive changes to society, health, and the environment. To highlight these, we started a new interview series about “Technology Making An Important Positive Social Impact”. We are interviewing leaders of tech companies who are creating or have created a tech product that is helping to make a positive change in people’s lives or the environment. As a part of this series, I had the pleasure of interviewing Dr. James Min, founder and CEO of Cleerly.

James K. Min, MD, is the Founder and CEO of Cleerly. Prior to Cleerly, Min served as a Professor of Radiology and Medicine (Cardiology) at Weill Cornell Medical College and the Director of the Dalio Institute of Cardiovascular Imaging (ICI) at NewYork-Presbyterian Hospital. He is a board-certified cardiologist with a clinical focus on cardiovascular disease prevention and cardiovascular imaging. For Min, the development, validation and dissemination of Cleerly’s AI-powered products and services–that are aimed at creating a new standard of precision heart care–offers him an opportunity to translate the large-scale clinical trial research he has spent conducting for nearly two decades into standard clinical practice through innovative solutions that have not existed in the marketplace to date.

Thank you so much for joining us in this interview series. Before we dive in, our readers would love to learn a bit more about you. Can you tell us a bit about your childhood backstory and how you grew up?

Thanks for taking the time to speak with me, Dave. I had a great, uneventful childhood. I was born in Norman, Oklahoma to my parents who were South Korean immigrants. I have one older brother, and we moved when I was very young to Whitewater, Wisconsin. Beyond a small state college in the town, the industry driving most of the economy was agriculture — dairy and soybean farming. I have fond memories — the people were amazing and it was a fantastic place to grow up. As a small child, however, ... Read full article HERE.

 

Cardiovascular Blind Spots and How Cleerly Is Changing the Game

Cardiovascular Blind Spots and How Cleerly Is Changing the Game

In The Future of Medicine Podcast, Aaron Wenzel, MD, and Jennifer Justus, MSN, APRN, FNP-C dive into how Cleerly has revolutionized their ability to...

Read More
AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...

Read More
Digital Health 50: The Most Promising Digital Health Companies of 2023

Digital Health 50: The Most Promising Digital Health Companies of 2023

Selected from more than 10,000 private healthcare companies, Cleerly is named one of CB Insight’s Digital Health 50 based on R&D, Mosaic scores,...

Read More
MedTech Strategist: Cleerly’s Personalized Approach to Heart Attack Risk

MedTech Strategist: Cleerly’s Personalized Approach to Heart Attack Risk

In this interview, Cleerly Founder and CEO, James Min, MD, shares how despite advances in cardiology, most heart attacks occur without warning....

Read More

Cleerly launches updated heart disease software

Cleerly has launched Cleerly 2.2.0, a new version of its software that includes user experience improvements and three new tools.

Read More

Cleerly's AI scans comparable to gold-standard angiography

Only a few months after it emerged from stealth and burst onto the medtech scene, Cleerly is already living up to its name.

Read More